Tempest Therapeutics Q1 Adj. EPS $(0.50) Misses $(0.28) Estimate
Benzinga Newsdesk 5 months ago
EarningsEarnings MissesNews
Tempest Therapeutics (NASDAQ:TPST) reported quarterly losses of $(0.50) per share which missed the analyst consensus estimate of $(0.28) by 78.57 percent. This is a 84.18 percent increase over losses of $(3.16) per share
Tempest Therapeutics (NASDAQ:TPST) reported quarterly losses of $(0.50) per share which missed the analyst consensus estimate of $(0.28) by 78.57 percent. This is a 84.18 percent increase over losses of $(3.16) per share from the same period last year.